Preclinical investigation of beta-amyloid mediated astrocyte glutamate transporter dysfunction: proof of concept for novel neuroprotective therapies in Alzheimer’s Disease
Preclinical investigation of beta-amyloid mediated astrocyte glutamate transporter dysfunction: proof of concept for novel neuroprotective therapies in Alzheimer’s Disease